Arrowpoint Investment Partners’s BioLife Solutions BLFS Stock Holding History

Arrowpoint Investment Partners’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$328K	Buy	+11,612	New	+$271K	0.07%	87

Other funds holding BLFS

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Arrowpoint Investment Partners's BLFS Position: Q2 2026 in Review

Arrowpoint Investment Partners opened a new position in BioLife Solutions (BLFS) in Q2 2026: 11,612 shares worth $328K. The stake represents 0.07% of the portfolio and ranks #87 among its holdings.

216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

Arrowpoint Investment Partners held 11,612 shares of BioLife Solutions worth $328K as of Q2 2026.
BioLife Solutions was a new Arrowpoint Investment Partners position in Q2 2026.
BioLife Solutions made up 0.07% of Arrowpoint Investment Partners's portfolio in Q2 2026, its #87 holding.
216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Arrowpoint Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.